HCA Healthcare

HCA · NYSE · USD

$426.69Change from previous close: +0.78%Absolute change: +$3.30

Close · October 2, 2026

At a glance

Revenue growth
+7.08%
2025 vs 2024
Net income growth
+17.78%
2025 vs 2024
Net margin
9.0%
2024: 8.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total assets63,25061,45060,72059,74759,536—
Current assets17,19016,05215,78315,28515,563—
Cash and equivalents1,0139401,040997939—
Receivables12,28111,32410,86710,42810,459—
Inventory1,6621,6811,6521,7341,792—
Net property, plant and equipment33,92533,56633,27132,68332,279—
Long-term investments1,2151,0021,1181,2271,185—
Current liabilities17,31219,25816,35017,89615,939—
Accounts payable4,7524,8064,6594,5524,250—
Long-term debt43,45439,49141,60338,40139,379—
Total debt51,55249,84548,69746,34946,364—
Total liabilities66,45964,42863,49161,90660,774—
Total equity (incl. minority)-3,209-2,978-2,771-2,159-1,238—
Retained earnings-6,310-5,978-5,724-5,020-4,087—
Minority interest3,4333,3253,2563,1763,156—